14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $23.53 $28.69 Friday, 3rd May 2024 INSM stock ended at $25.55. This is 0.429% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.06% from a day low at $25.40 to a day high of $26.43.
90 days $23.53 $29.91
52 weeks $18.09 $32.00

Historical Insmed prices

Date Open High Low Close Volume
Aug 23, 2023 $21.55 $22.19 $21.51 $22.09 1 202 164
Aug 22, 2023 $21.97 $22.11 $21.64 $21.65 559 916
Aug 21, 2023 $21.61 $22.44 $21.21 $22.00 1 323 238
Aug 18, 2023 $21.78 $22.25 $21.68 $21.73 977 776
Aug 17, 2023 $22.61 $22.74 $21.69 $21.97 786 755
Aug 16, 2023 $22.42 $22.98 $22.24 $22.53 909 942
Aug 15, 2023 $22.30 $22.64 $22.15 $22.51 764 229
Aug 14, 2023 $22.24 $22.53 $21.73 $22.30 886 321
Aug 11, 2023 $22.71 $22.98 $22.30 $22.43 1 049 455
Aug 10, 2023 $21.52 $22.98 $21.52 $22.72 1 374 931
Aug 09, 2023 $22.03 $22.27 $21.38 $21.52 1 813 263
Aug 08, 2023 $21.96 $22.34 $21.69 $22.05 1 624 235
Aug 07, 2023 $22.01 $22.16 $21.66 $21.87 1 772 580
Aug 04, 2023 $22.15 $22.64 $21.98 $21.99 1 564 486
Aug 03, 2023 $20.99 $22.65 $20.97 $22.15 1 887 430
Aug 02, 2023 $22.04 $22.04 $21.46 $21.77 1 034 090
Aug 01, 2023 $22.03 $22.20 $21.62 $22.13 1 251 947
Jul 31, 2023 $21.39 $22.22 $21.30 $22.09 1 203 259
Jul 28, 2023 $20.50 $21.40 $20.48 $21.35 1 604 316
Jul 27, 2023 $20.50 $20.70 $20.34 $20.40 779 656
Jul 26, 2023 $21.04 $21.21 $20.28 $20.36 1 014 395
Jul 25, 2023 $20.38 $20.46 $20.16 $20.22 630 253
Jul 24, 2023 $21.09 $21.22 $20.34 $20.46 896 476
Jul 21, 2023 $21.40 $21.91 $21.07 $21.08 1 085 857
Jul 20, 2023 $21.11 $21.37 $20.98 $21.29 648 019
Click to get the best stock tips daily for free!

About Insmed

Insmed Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutr... INSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT